United States

Analyst Research Report Snapshot


Sartorius Stedim Biotech S.A.






26 Jan 2015





Companies referenced:

Available for Immediate Download

Sartorius Stedim Biotech S.A. - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Sartorius Stedim Biotech S.A. required for business and competitor intelligence needs - Intelligence on Sartorius Stedim Biotech S.A.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Sartorius Stedim Biotech S.A., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Sartorius Stedim Biotech (SSB) (formerly Stedim Biosystems) is a provider of equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. The company operates in Europe, the Americas, Africa and Asia Pacific. It is headquartered in Aubagne, France, and employs around 3,300 people. The company recorded revenues of E588.4 million (approximately $781.5 million) in the fiscal year ended December 2013, an increase of 8.2% over 2012. The company's operating profit was E101.3 million (approximately $134.6 million) in fiscal 2013, an increase of 18.4% over 2012. Its net profit was E66.3 million (approximately $88 million) in fiscal 2013, an increase of 16.8% over 2012. Reasons to Purchase: - Gain understanding of Sartorius Stedim Biotech S.A. the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Sartorius Stedim Biotech S.A. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Sartorius Stedim Biotech S.A. your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.